Artificial intelligence has been a big theme in the world of health and medical research, and specifically in the area of drug discovery. Today, another hopeful in the space is announcing a funding round to expand its own contribution to the field. Causaly, a London startup that has built an AI platform to help researchers […]
Causaly, an AI platform for drug discovery and biomedical research, raises $60M by Ingrid Lunden originally published on TechCrunch...